, /PRNewswire/ -- DelveInsight's report includes a comprehensive understanding of current treatment practices, binge eating disorder emerging drugs, market share of individual therapies, and current and forecasted market size from 2020 to 2034, segmented into 7MM [ , the EU4 ( , , , and ) and the , and ]. Discover which therapies are expected to grab the major binge eating disorder market share @ Binge eating disorder is a serious mental health condition characterized by recurrent episodes of consuming large quantities of food in a short period while feeling a loss of control over eating behavior. Unlike bulimia nervosa, individuals with binge eating disorder typically do not engage in compensatory behaviors such as purging or excessive exercise to counteract the binge eating episodes.
Several factors contribute to the development of binge eating disorder, including genetic predisposition, psychological factors like stress or low self-esteem, and environmental influences such as societal pressure to attain certain body ideals. Traumatic life events, childhood experiences, and dysfunctional family dynamics may also play a role in its onset. Symptoms of binge eating disorder include eating unusually large amounts of food in a specific time frame, eating rapidly until feeling uncomfortably full, eating alone due to embarrassment over food intake, and experiencing feelings of guilt, shame, or distress after binge eating episodes.
Individuals with BED often struggle with emotional.
